Supernus Pharmaceuticals (SUPN) Change in Taxes (2016 - 2020)
Supernus Pharmaceuticals has reported Change in Taxes over the past 5 years, most recently at -$25.1 million for Q3 2020.
- Quarterly Change in Taxes fell 1268.42% to -$25.1 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was -$4.9 million through Sep 2020, down 31.72% year-over-year, with the annual reading at -$9.9 million for FY2019, 178.97% down from the prior year.
- Change in Taxes was -$25.1 million for Q3 2020 at Supernus Pharmaceuticals, down from $15.9 million in the prior quarter.
- Over five years, Change in Taxes peaked at $15.9 million in Q2 2020 and troughed at -$25.1 million in Q3 2020.
- The 5-year median for Change in Taxes is $782000.0 (2016), against an average of -$5000.0.
- Year-over-year, Change in Taxes skyrocketed 7481.82% in 2017 and then tumbled 24176.12% in 2018.
- A 5-year view of Change in Taxes shows it stood at -$804000.0 in 2016, then surged by 1275.25% to $9.4 million in 2017, then plummeted by 59.48% to $3.8 million in 2018, then tumbled by 162.03% to -$2.4 million in 2019, then plummeted by 954.78% to -$25.1 million in 2020.
- Per Business Quant, the three most recent readings for SUPN's Change in Taxes are -$25.1 million (Q3 2020), $15.9 million (Q2 2020), and $6.7 million (Q1 2020).